BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

738 related articles for article (PubMed ID: 9499087)

  • 1. CD4 glycoprotein degradation induced by human immunodeficiency virus type 1 Vpu protein requires the function of proteasomes and the ubiquitin-conjugating pathway.
    Schubert U; Antón LC; Bacík I; Cox JH; Bour S; Bennink JR; Orlowski M; Strebel K; Yewdell JW
    J Virol; 1998 Mar; 72(3):2280-8. PubMed ID: 9499087
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapid degradation of CD4 in cells expressing human immunodeficiency virus type 1 Env and Vpu is blocked by proteasome inhibitors.
    Fujita K; Omura S; Silver J
    J Gen Virol; 1997 Mar; 78 ( Pt 3)():619-25. PubMed ID: 9049413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vpu-mediated degradation of CD4 reconstituted in yeast reveals mechanistic differences to cellular ER-associated protein degradation.
    Meusser B; Sommer T
    Mol Cell; 2004 Apr; 14(2):247-58. PubMed ID: 15099523
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human immunodeficiency virus type 1 Vpu protein induces degradation of chimeric envelope glycoproteins bearing the cytoplasmic and anchor domains of CD4: role of the cytoplasmic domain in Vpu-induced degradation in the endoplasmic reticulum.
    Vincent MJ; Raja NU; Jabbar MA
    J Virol; 1993 Sep; 67(9):5538-49. PubMed ID: 8350411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ubiquitination is required for the retro-translocation of a short-lived luminal endoplasmic reticulum glycoprotein to the cytosol for degradation by the proteasome.
    de Virgilio M; Weninger H; Ivessa NE
    J Biol Chem; 1998 Apr; 273(16):9734-43. PubMed ID: 9545309
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Requirements for the selective degradation of CD4 receptor molecules by the human immunodeficiency virus type 1 Vpu protein in the endoplasmic reticulum.
    Binette J; Dubé M; Mercier J; Halawani D; Latterich M; Cohen EA
    Retrovirology; 2007 Oct; 4():75. PubMed ID: 17937819
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The human immunodeficiency virus type 1 Vpu protein inhibits NF-kappa B activation by interfering with beta TrCP-mediated degradation of Ikappa B.
    Bour S; Perrin C; Akari H; Strebel K
    J Biol Chem; 2001 May; 276(19):15920-8. PubMed ID: 11278695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involvement of the betaTrCP in the ubiquitination and stability of the HIV-1 Vpu protein.
    Belaïdouni N; Marchal C; Benarous R; Besnard-Guérin C
    Biochem Biophys Res Commun; 2007 Jun; 357(3):688-93. PubMed ID: 17445772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vpu directs the degradation of the human immunodeficiency virus restriction factor BST-2/Tetherin via a {beta}TrCP-dependent mechanism.
    Douglas JL; Viswanathan K; McCarroll MN; Gustin JK; Früh K; Moses AV
    J Virol; 2009 Aug; 83(16):7931-47. PubMed ID: 19515779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human immunodeficiency virus type 1 Vpu protein induces rapid degradation of CD4.
    Willey RL; Maldarelli F; Martin MA; Strebel K
    J Virol; 1992 Dec; 66(12):7193-200. PubMed ID: 1433512
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of glucose trimming with castanospermine reduces calnexin association and promotes proteasome degradation of the alpha-subunit of the nicotinic acetylcholine receptor.
    Keller SH; Lindstrom J; Taylor P
    J Biol Chem; 1998 Jul; 273(27):17064-72. PubMed ID: 9642271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteasome-dependent degradation of the human estrogen receptor.
    Nawaz Z; Lonard DM; Dennis AP; Smith CL; O'Malley BW
    Proc Natl Acad Sci U S A; 1999 Mar; 96(5):1858-62. PubMed ID: 10051559
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The two biological activities of human immunodeficiency virus type 1 Vpu protein involve two separable structural domains.
    Schubert U; Bour S; Ferrer-Montiel AV; Montal M; Maldarell F; Strebel K
    J Virol; 1996 Feb; 70(2):809-19. PubMed ID: 8551619
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Degradation of a mutant secretory protein, alpha1-antitrypsin Z, in the endoplasmic reticulum requires proteasome activity.
    Qu D; Teckman JH; Omura S; Perlmutter DH
    J Biol Chem; 1996 Sep; 271(37):22791-5. PubMed ID: 8798455
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vpu-induced degradation of CD4: requirement for specific amino acid residues in the cytoplasmic domain of CD4.
    Lenburg ME; Landau NR
    J Virol; 1993 Dec; 67(12):7238-45. PubMed ID: 8230446
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vpu-mediated proteolysis of gp160/CD4 chimeric envelope glycoproteins in the endoplasmic reticulum: requirement of both the anchor and cytoplasmic domains of CD4.
    Raja NU; Vincent MJ; abdul Jabbar M
    Virology; 1994 Oct; 204(1):357-66. PubMed ID: 8091666
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The human immunodeficiency virus type 1 Vpu protein: a potential regulator of proteolysis and protein transport in the mammalian secretory pathway.
    Vincent MJ; Abdul Jabbar M
    Virology; 1995 Nov; 213(2):639-49. PubMed ID: 7491787
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel human WD protein, h-beta TrCp, that interacts with HIV-1 Vpu connects CD4 to the ER degradation pathway through an F-box motif.
    Margottin F; Bour SP; Durand H; Selig L; Benichou S; Richard V; Thomas D; Strebel K; Benarous R
    Mol Cell; 1998 Mar; 1(4):565-74. PubMed ID: 9660940
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transmembrane domain determinants of CD4 Downregulation by HIV-1 Vpu.
    Magadán JG; Bonifacino JS
    J Virol; 2012 Jan; 86(2):757-72. PubMed ID: 22090097
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The human immunodeficiency virus type 1 Vpu protein specifically binds to the cytoplasmic domain of CD4: implications for the mechanism of degradation.
    Bour S; Schubert U; Strebel K
    J Virol; 1995 Mar; 69(3):1510-20. PubMed ID: 7853484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.